Early-stage oncology biotechs shouldn't have to choose between affordable imaging and regulatory-grade quality.                                             
    
Volumetryx is the central imaging partner for Phase I/II oncology trials, built for small and medium sized teams running their first or next study.                    
                                                                                                            
Core services                                                                                                                                               
 → DICOM Collect & Hold - real-time QA, adaptive trial-ready                                               
 → Central Read (BICR) - RECIST 1.1, RANO 2.0, Lugano,                                                                                            
 → Advanced Image Analysis - Quantitative imaging biomarkers
                                                                                                                                                              
Modalities: PET/CT, MRI, CT across solid tumors, lymphoma, GBM, HCC, prostate, breast, H&N, sarcoma, myeloma.                                               
                                                                                                                                                              
Compliance: FDA 21 CFR Part 11 · HIPAA · GDPR                                                                                                               
                                                                                                          
Turnaround: 24–72 hr reads. Pricing that fits a Series A budget.                                                                                            

Running a Phase I/II oncology trial — or planning one in the next 6 months? Book a 30-min demo: app.volumetryx.ai

Volumetryx

Org chart

Teams

Offices

Volumetryx

Org chart

Teams

Offices

Related companies